395 WINCHESTER AVE, NEW HAVEN, CT
Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Election of Class II Directors at Arvinas, Inc. Annual Meeting
Departure of Chief Medical Officer - Noah Berkowitz to Leave Arvinas, Inc.
Other Events
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership